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Abstract  
Immunity plays an important role in the prognosis and the natural development of cancer. Previous studies 
have shown that the presence of tumor in the body could modify the immune response leading to immunosuppression. 
The aim of this study was to evaluate the immunological changes of patients with larynx squamous cell carcinoma 
undergoing potentially curative surgery. We assessed the serum levels of cytokines (IL-1, IL-2, IL-4, IL-6, IL-8, IL-10, 
IFN-gamma, TNF-alpha, GM-CSF), chemokines (MCP-1 and MIP-1alpha) and growth factors (VEGF and bFGF) in 
laryngeal  cancer  patients  before,  during  and  after  surgery.  We  have  used  a  novel  multianalyte  XMap  profiling 
technology that allows simultaneous measurement of multiple parameters in small volumes of samples. To investigate 
the changes in immune mediators’ profile induced by tumor resection, we assessed the culture supernatants of the 
peripheral blood mononuclear cells (PBMC) derived from the patients, before and after surgery. The results suggested a 
predominance of a Th2 type of immune response associated with the presence of the tumor (especially in the case of 
heavy smokers who smoke more than 40 pack-years). However, shifts towards a Th1 type of immune response as well 
as an improvement of monocyte functions were noticed after surgery. 
 
Introduction 
 
Larynx  cancer  is  an  aggressive  disease 
accompanied,  among  others,  by  changes  in  the 
mediators  involved  in  the  immune  response, 
inflammation  and  angiogenesis.  A  better 
understanding of these disorders can contribute to 
an early diagnosis, improved prognosis and some 
new  therapeutic  opportunities.  There  were 
approximately 12,250 new cases of larynx cancer 
diagnosed  in  2008  in  the  U.S.,  9680  men  and 
2570  women  [1,2].  This  type  of  cancer  is  now 
frequently  diagnosed  in  younger  patients  (40-50 
years old) and despite the improved diagnosis and 
treatment, the mortality rate of larynx cancer has 
not changed significantly (5 year-survival rate of 
64%) [1-4]. Among the causes of the low survival 
rate  are  the  lack  of  screening  methods  (clinical 
examination remains the single solution to early 
detection) and the late presentation of patients to 
the  specialist  as  a  result  of  little  worrying 
symptoms  (hoarseness)  [5].  Tromp  and 
collaborators  have  shown  that  the  lack  of 
suspicion  of  cancer  at  the  first  consultation  is 
associated with delay in the second consultation 
among  patients  who  were  not  diagnosed  with 
cancer initially [6]. 
Smoking, alcohol and malnutrition are the 
main  risk  factors  in  laryngeal  cancer.  The  risk 
increases  with  the  number  of  smoked  cigarettes 
and the number of smoking years. The association 
of  smoking  with  alcohol  consumption  increases 
the  risk  of  laryngeal  cancer  occurrence  by 
approximately  30  times  [1],  alcohol  favoring 
carcinogens  penetration  through  mucosa  by 
vasodilatation.  Quitting  smoking  and  reducing 
alcohol  consumption  are  the  most  effective 
methods for primary prevention. 
 
Cytokines  in  the  squamous  cell 
carcinoma of the larynx 
The  relationship  between  immunity  and 
cancer is bivalent. A decrease in immunity may 
influence  cancer  occurrence  and  tumor  causes  a 
decrease  in  immunity,  thus  creating  a  vicious 
circle.  Molecular  mechanisms  involved  in 
immunosuppression  and  mechanisms,  by  which 
tumors  avoid  immune  response  of  the  host, 
remain  mostly  unknown.  Cytokines  are 
glycoproteins that act as mediators of immunity. It was 
shown that the evolution of the laryngeal squamous 
cell carcinoma is associated with changes in the levels 
of  several  cytokine  such  as  IL-4,  IL-6,  IL-8, 
IL-10,  GM-CSF  (granulocyte  macrophage  colony-
stimulating  factor),  VEGF  (vascular  endothelial 
growth factor), bFGF (basic fibroblast growth factor) 
[7-11].  
It  was  also  suggested  that  high  levels  of 
immunosuppressive  cytokines  are  related  to  the Journal of Medicine and Life  Vol. 2, No.2, April-June 2009  
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mechanisms  used  by  laryngeal  squamous  cell 
carcinoma  in  order  to  avoid  destruction  by  the 
immune system. Cytokines involved in squamous 
cell carcinoma of the larynx and their functions 
are presented in Table 1. 
 
Cytokines  Cellular functions 
IL-1  Cytokine secretion, 
IL-4  Immune suppresion 
IL-6  Inflammation regulation, antiapoptosis 
IL-8  Angiogenesis 
IL-10  Immune suppresion 
HGF  Angiogenesis 
MIF  Growth regulation 
PDGF  Angiogenesis 
PGE2  Immune suppresion 
TGF-β  Immune suppresion 
VEGF  Angiogenesis, metastasis, chemoattraction 
bFGF  Angiogenesis, metastasis 
GM-CSF  CD34 mobilisation, immune supression 
 
 
 
 
 
 
 
 
 
 
 
Angiogenesis  factors  in  the  squamous 
cell carcinoma of the larynx 
Angiogenesis, defined as the sprouting of 
new vessels from pre-existing ones, is concededly 
one  of  the  key-steps  in  tumor  growth  and 
progression.  Angiogenesis  is  initiated  by 
paracrine release of specific growth factors such 
as  VEGF,  bFGF,  PDGF,  GM-CSF  and  G-CSF 
[12,13]. It has been shown that VEGF is crucial
 in 
sustaining,  but  not  initiating,  angiogenesis  by 
malignant
  squamous  cells,  and  that  other 
angiogenic  factor(s)  mediates
  early-stage  tumor 
angiogenesis.    VEGF  was  associated  with  the 
tumor  progression  and  the  aggressive  tumor 
phenotype [14]. Tumors secreting simultaneously 
three  or  more  growth  factors  indicate  a  worse 
patient prognosis [12].  
A  new  identified  growth  factor  is  MIF 
(macrophage migration inhibitory factor). Suzuki 
and  collaborators  have  shown  that  patients  with 
MIF-negative tumors have a worse prognosis than 
those  with  MIF-positive  tumors,  the  last 
responding  much  better  to  chemotherapy 
(carboplatin) [15]. 
Th1/Th2  cytokines  profile  in  larynx 
cancer 
There  are  two  major  types  of  immune 
response associated with the production of distinct 
sets  of  cytokines.  Cellular  immune  response  is 
associated  with  preferential  involvement  of  Th1 
phenotype  T  helper  lymphocytes  (Th)  and 
production of IFN-, IL-2 and IL-12. Preferential 
involvement of Th2 phenotype is associated with 
the  development  of  humoral  immune  response, 
and  main  Th2  cytokines  are  IL-4  and  IL-10.  In 
healthy  individuals,  there  is  a  balance  between 
these two types of immune response [16]. Being 
an  effective  predominantly  cellular  anti-tumor 
immune  response  (Th1  phenotype),  it  is 
considered that a predominant Th2 response may 
be involved in the tumor progression and/or it is 
associated  to  immunosuppression.  Studies  in 
literature show that there is a change in immune 
profile from Th1 to Th2 in patients with laryngeal 
squamous  cell  carcinoma,  resulting  in  inhibition 
of cellular immune response [17,18]. 
In this study, we assessed immunological 
changes in patients with laryngeal squamous cell 
carcinoma  undergoing  surgery  in  curative 
purpose.  For  this  purpose,  the  cytokines, 
chemokines  and  growth  factors  patterns  were 
determined in patients’ serum before surgery (3-4 
days), during the surgical act and at 5-7 days after 
surgery.  
To  investigate  the  changes  in  immune 
mediators’ profile induced by tumor resection, we 
assessed  the  culture  supernatants  of  peripheral 
blood  mononuclear  cells  (PBMC)  derived  from 
the  patients,  before  and  after  surgery.  We  used 
Multiplex  xMAP  technology,  which  allows 
simultaneous determination of several parameters, 
in a small volume of sample. 
 
Materials and methods 
 
Patients 
10 patients diagnosed with squamous cell 
carcinoma  of  the  larynx,  undergoing  surgery  in 
the ENT-Department, "Sf. Maria" Hospital during 
September 2007 ÷ November 2008 were enrolled 
in  this  study.  The  study  was  approved  by  the 
Ethics  Committee  of  "Sf.  Maria"  Hospital  and 
inclusion  in  the  study  and  sampling  was  done 
after  obtaining  written  informed  consent  of 
subjects.  The  control  group  consisted  of  10 
healthy donors. 
 
Determination of immune mediators 
Cytokines  and  chemokines  were 
measured  both  in  serum  (before  surgery,  during 
the  surgery  and  after  the  surgery)  and  PBMC 
Table 1 Squamous cell carcinoma of the larynx – 
relevant cytokines and their cellular functions HGF: 
Hepatocyte  growth  factor,  MIF:  Macrophage 
migration inhibitory factor, PDGF: Platelet-derived 
growth  factor,  PG:  prostaglandin,  TGF-
β:Transforming  growth  factor,  VEGF:Vascular 
endothelial  growth  factor,  bFGF  basic  fibroblast 
growth  factor,  GM-CSF:  granulocyte  macrophage 
colony stimulating factor. 
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(peripheral  blood  mononuclear  cells)  culture 
supernatants.  
Peripheral  blood  collected  by  venous 
puncture in heparin tubes (100U/mL blood) was 
immediately  diluted  1:1  with  culture  medium 
(RPMI1640  supplemented  with  100U/mL 
penicillin,  100g/mL  streptomycin,  and  1mM 
glutamine).  PBMC  cells  were  isolated  using 
gradient density centrifugation (30min, 2000rpm, 
21
oC,  Histopaque®-1077,  Sigma).  After  the 
centrifugation,  the  mononuclear  cell  ring  was 
collected and cells were washed three times with 
medium culture (each followed by centrifugation 
10min,  1500,  1200  and  1000rpm,  respectively). 
PBMC  were  resuspended  in  complete  medium 
culture  (RPMI1640  supplemented  with  100U/mL 
penicillin,  100g/mL  streptomycin,  1mM 
glutamine  and  10%  fetal  calf  serum,  SFV), 
counted, plated at concentration of 1.5 x 10
6cel/ml 
(200L/well) in 96-well plates  and incubated in 
the  presence  of  phytohemmagglutinin  (PHA,  5 
g/ml)  or  E.coli  lipopolysaccharide  (LPS, 
1g/mL) for 24 h at 37
oC in the presence of 5% 
CO2.    Culture  wells  stimulated  with  phosphate 
buffered  saline  (PBS)  were  used  as  negative 
controls. Culture supernatants were collected after 
24h of centrifuged incubation (5 min, 1200 rpm) 
and  tested  on  Luminex
  100  platform.  The 
following mediators were tested in sera: TNF-, 
IL-6, IL-10, MIP-1 (macrophage inflammatory 
protein),  VEGF  (vascular  endothelial  growth 
factor),  bFGF  (basic  fibroblast  growth  factor), 
MCP  -1  (monocyte  chemoattractant  protein) 
(using Human Multianalyte Profiling Base Kit A, 
R&D  Systems).  The  following  parameters  were 
tested in PBMC culture supernatants: IFN-, IL-
1, IL-1Ra (IL-1 receptor antagonist), IL-2, IL-4, 
IL-10, using the Milliplex MAP kit (Millipore). 
Plate  reading  was  performed  on  the  Luminex
 
100    platform  and  data  were  processed  with 
Luminex  100  IS  2.3  Star  Station  software 
(separate  results  in  MFI:  Mean  Fluorescence 
Intensity  and  concentrations,  pg/mL,  for  each 
mediator). 
 
Statistical analysis 
The results are reported as median values, 
range  of  variation  (25
th  to  75
th  percentiles)  and 
standard  error  of  the  mean.  Statistical  analysis 
was  performed  by  unpaired  Mann-Whitney  test 
using SPSS 9.0 software. Statistical significance 
was defined as a two-sided P value of less than 
0.05. 
 
Results 
 
The  demographic  and  clinical  characteristics  of 
patients  included  in  the  study  are  presented  in 
Table 2. 
Characteristic  Value 
Age, year (average)  54 ± 7.1 
Sex: 
  male 
  female 
 
8 
2 
Stage : 
  T1 
  T2 
  T3 
  T4 
 
1 
3 
5 
1  
Stage: 
  N0 
  N1 
  N2 
 
5 
2 
3  
Location: 
  supraglottic 
  glottic 
  subglottic 
 
4 
9 
3 
 
 
 
 
The  patients  were  clinically  evaluated 
(anamnesis,  clinical  ENT  examination,  general 
physical  examination,  anesthesiology 
examination),  by  laboratory  tests, 
laryngofibroscopy,  computed  tomography  and 
anatomopathological  exam.  All  patients 
underwent surgical treatment in "Sf. Maria" ENT 
Clinical  Hospital,  consisting  of  partial  or  total 
laryngectomy. Anamneses data, disease onset and 
development  until  the  time  of  presentation  are 
presented in Table 3. 
 
 
Smoker 
Packs - year 
 
Alcohol 
consumption 
Hoarseness  
(months) 
45  Yes  5 
60  Yes   12 
30  Yes  12 
20  Yes  24 
52,5  Yes  3 
70  Yes  24 
25  Yes  6 
90  No  8 
0  No  2 
45  No  12 
 
 
 
There was a predominance of smokers, 9 
of 10 patients, with an average of 45 pack-years (a 
pack-year is equivalent to smoking 20 cigarettes 
daily for one year), a minimum of 20 pack-years, 
and a maximum of 90 pack-years. Seven of the 
patients  declared  that  they  were  chronic  alcohol 
Table 2. Clinical and demographic characteristics 
of patients (n=10) 
 
Table 3 Anamneses data Journal of Medicine and Life  Vol. 2, No.2, April-June 2009  
  214 
© 2009, Carol Davila University Foundation 
consumers. Patients were presented at an average 
of  10  months  after  onset  of  hoarseness,  late 
presentation to the practitioner having the result 
that  a  large  percentage  of  patients  were  in 
advanced stages of disease.  
The  determination  of  cytokines, 
chemokines  and  growth  factors  was  performed 
using  a  Milliplex  MAP  (Millipore)  kit  on 
Luminex  platform
  100  as  described  in 
“Materials  and  methods”.  The  serum  level  of 
inflammatory mediators (IL-6, TNF, MCP-1 and 
MIP-1), anti-inflammatory cytokine (IL-10) and 
growth factors VEGF and bFGF were measured 
for the patients at three moments in time, namely 
before  the  surgery,  during  the  surgery  and  after 
the  surgery.  The  results  are  presented  in  Fig.  1 
and Fig. 2. 
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Fig. 1 Serum levels of pro-inflammatory cytokines 
IL-6(a), anti-inflammatory  cytokine IL-10(b), pro-
inflammatory  cytokines  TNF-alpha(c)  and 
chemokine MIP-1alpha(d) before, during and after 
surgery  compared  to  normal  values  (n=10). 
Statistically significant compared to normal values 
by Mann-Whitney test. 
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As  it  can  be  seen,  the  patients  had 
increased levels of IL-6, TNF-, IL-10, MIP-1 
and  bFGF  compared  to  healthy  controls, 
regardless  of  the  time  of  measuring.  The 
differences  reached  a  statistical  significance  for 
IL-6 measured either before or after the surgery 
(P<0.01 vs. control group). Moreover, the serum 
concentrations  of  all  the  mediators  measured 
during  surgery  were  statistically  significantly 
higher than the control group.  
Cytokine  levels  were  also  measured  in 
PBMC  culture  supernatants,  before  and  after 
surgery (Fig. 3 and Fig. 4). We noticed a trend 
towards  improvement  of  cellular  response 
(evaluated by the level of IFN- and IL-2 secreted 
by  T  lymphocytes  stimulated  with  PHA)  after 
surgery,  although  the  differences  were  not 
statistically  significant.  Moreover,  a  slight 
decrease in IL-4 and IL-10 levels (Fig. 4) as well 
as an increase of IL-1 and IL-1Ra after surgery, 
was noticed (Fig. 5). 
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Fig.  2  Serum  levels  of  growth  factors  VEGF(a), 
MCP 1(b),  bFGF(c)  before,  during  and  after 
surgery  compared  to  normal  values.  Statistically 
significant  compared  to  normal  values  by  Mann-
Whitney test. 
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Fig. 3 Median values of concentrations of IFN- (a), IL-2 (b) in culture supernatants of PBMC isolated from 
patients with laryngeal cancer before and after surgery (n = 10). 
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Fig. 4 Median values of concentrations of IL-4 (a) and IL-10 (b) in culture supernatants of PBMC isolated from 
patients with laryngeal cancer before and after surgery (n = 10). 
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When analyzing the results in the clinical 
context  we  noticed  a  statistically  significant 
difference  between  the  IL-4  levels  in  PBMC 
culture supernatants, in the subgroup of patients 
who smoked more than 40 pack-years compared 
to  those  who  smoked  less  than  40  pack-years, 
which  suggests  an  influence  of  smoking  on  the 
immune response (Fig. 6). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Discussion 
 
In  this  study,  we  examined  several 
immune  parameters  in  patients  with  squamous 
cell carcinoma of the larynx, preoperatively and 
postoperatively,  in  an  attempt  to  identify  the 
changes  induced  by  the  presence  of  the  tumor 
and/or  surgical  act.  We  have  used  the  xMAP 
novel technology, which proved to be an effective 
approach  to  investigate  complex  networks  (such 
as  cytokines  network  that  controls  the  Th1/Th2 
balance) [19]. 
Our  results  revealed  distinct 
immunological  profiles  before,  during  and  after 
operation.  Before  surgery,  the  serum 
concentration  of  IL-6  was  statistically  and 
significantly  higher  in  cancer  patients  than  in 
healthy  controls  (P  <0.01,  Mann-Whitney  test) 
which,  according  to  the  literature  data,  suggests 
that  the  tumor  is  associated  with  inflammation 
[20,21].  An  inflammatory  response  was  noticed 
during the operation, which was characterized by 
a statistically significant increase in concentration 
of  all  tested  inflammatory  mediators  versus 
control group. Increased concentration of growth 
factors VEGF and bFGF (statistically significant 
for bFGF, P <0.05 – before and after surgery, and 
P <0.01 –during surgery) could be explained by 
the involvement of these factors both in the neo-
angiogenesis (before surgery) and in the repairing 
of  the  tissue  (during  and  after  surgery). 
Surprisingly,  serum  levels  of  MCP-1  in  cancer 
patients  were  lower  than  in  control  group 
(statistically  significant,  P<0.05,  after  surgery). 
The monocyte chemo attractant protein-1 (MCP-
1) has been shown to act as a chemokine in the 
recruitment  of  monocyte/macrophages  during 
inflammation states. It acts as an important factor 
in  the  cytokine  network,  which  regulates  tumor 
proliferation.  However,  literature  data  are 
controversial  regarding  the  level  of  MCP-1  in 
cancer  patients.  Several  studies  indicated  an 
increase  of  the  MCP-1  in  breast  cancer  and 
melanoma  [22,  23]  and  others  showed  that  in 
patients with gastric cancer, serum level of MCP-
1  decreased  according  to  the  progression  of  the 
disease, probably reflecting its local consumption 
[24].  
In this study, the cytokine production in 
PBMC of patients with larynx cancer stimulated 
ex  vivo  was  analyzed  before  and  after  the 
operation. A trend towards an improved cellular 
immune  response  (increased  amounts  of  IFN- 
and  IL-2)  was  noticed  after  surgery.  A  slight 
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Fig.  5 Median values of concentrations of IL-1 (a) and IL-1Ra (b) in culture supernatants of PBMC isolated 
from patients with laryngeal cancer before and after surgery (n = 10). 
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supernatants of PBMC, according to the number of 
cigarettes  smoked,  before  and  after  surgery. 
Statistically significant compared to normal values 
by Mann-Whitney test. 
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decrease  in  the  level  of  IL-4  (a  prototype  Th2 
cytokine)  and  IL-10  was  also  noticed  after 
surgery.  Although  differences  were  not 
statistically  significant,  they  might  suggest  that 
Th1/Th2 balance shifts towards Th2 dominance in 
patients  after  surgery,  hypothesis  supported  by 
literature  data  [18,  21].    On  the  other  hand,  an 
increase  of  IL-1  (a  pro-inflammatory  cytokine) 
and  IL-1Ra  anti-inflammatory  mediator  was 
noticed  postoperatively,  which  suggests  an 
improvement  in  monocyte  functions.  There  was 
no  correlation  between  the  level  of  cytokines 
determined  in  the  culture  supernatant  of  PBMC 
and the serum levels of cytokines or the clinical 
data of patients (stage, degree of differentiation, 
tumor size or location or number of lymph node 
metastasis).  However,  when  larynx  cancer 
patients were divided in two subgroups, according 
to their smoking status, we noticed a statistically 
significant  difference  in  the  level  of  IL-4 
produced  by  T  lymphocytes,  i.e.  patients  who 
smoked  more  than  40  pack-years  had  increased 
levels of this cytokines (P <0.05, vs. patients who 
smoked  less  than  40  pack-years).  This  is 
considered  an  important  finding,  as  increased 
levels of IL-4 characterize a Th-2 type of immune 
response.  Recent  literature  data  showed  that  a 
predominant Th2-type response was induced by 
 
References 
components  extracted  from  cigarette  smoke  through 
the suppression of dendritic cell function [25]. 
 
Conclusions 
 
This  study  illustrates  different  cytokine 
patterns in serum and PBMC culture supernatants 
for patients with larynx squamous cell carcinoma 
undergoing  potentially  curative  surgery.  An 
inflammatory pattern associated with the presence 
of  the  tumor  was  identified.  Our  results  also 
revealed the inflammatory status associated with  
surgery and suggested a shift towards a Th1-type 
of  immune  response  postoperatively.  A 
predominance  of  the  Th2-type  of  immune 
response  was  identified  for  heavy  smokers. 
Despite the limitation related to the small number 
of  patients  investigated,  the  results  provide 
important  information  on  the  immunological 
changes  in  patients  with  laryngeal  cancer,  after 
surgery.  Further  studies  are  needed  to  evaluate 
these changes on a larger number of patients and 
for a longer period of time after surgery. 
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